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A highly discriminative and information-rich diagnostic assay for H5N1 avian influenza would meet immediate patient care
needs and provide valuable information for public health interventions, e.g., tracking of new and more dangerous variants by
geographic area as well as avian-to-human or human-to-human transmission. In the present study, we have designed a rapid
assay based on multilocus nucleic acid sequencing that focuses on the biologically significant regions of the H5N1
hemagglutinin gene. This allows the prediction of viral strain, clade, receptor binding properties, low- or high-pathogenicity
cleavage site and glycosylation status. H5 HA genes were selected from nine known high-pathogenicity avian influenza
subtype H5N1 viruses, based on their diversity in biologically significant regions of hemagglutinin and/or their ability to cause
infection in humans. We devised a consensus pre-programmed pyrosequencing strategy, which may be used as a faster, more
accurate alternative to de novo sequencing. The available data suggest that the assay described here is a reliable, rapid,
information-rich and cost-effective approach for definitive diagnosis of H5N1 avian influenza. Knowledge of the predicted
functional sequences of the HA will enhance H5N1 avian influenza surveillance efforts.
Citation: Pourmand N, Diamond L, Garten R, Erickson JP, Kumm J, et al (2006) Rapid and Highly Informative Diagnostic Assay for H5N1 Influenza
Viruses. PLoS ONE 1(1): e95. doi:10.1371/journal.pone.0000095
INTRODUCTION
The worldwide spread of high-pathogenicity H5N1 avian in-
fluenza A virus in poultry and wild birds has resulted in many
human infections, with high fatality rates. Although sustained
human-to-human transmission has not yet occurred, concern
about a potential pandemic continues to mount. The current HA
lineage of H5N1 avian influenza was first found among domestic
poultry populations in 1996 in southern China [1]. A similar
H5N1 influenza virus spread directly from poultry to humans in
Hong Kong in 1997, causing death in 6 out of 18 persons
diagnosed with infection with this virus [2]. While the massive
culling of poultry in 1997 temporarily eradicated the virus in Hong
Kong, the virus has continued to spread across Asia, causing
human deaths in Thailand, Vietnam, Indonesia, China and
elsewhere [2,3]. The rapid spread of H5N1 in birds from Asia into
Europe and Africa in recent months has intensified efforts to
control the virus and avert a pandemic. To address the recognized
need for rapid, low-cost diagnosis, tracking critically important
genetic changes in the virus among animal and human host
populations, and identifying specific viral clades [4], we have
developed high-throughput methods for monitoring viral muta-
tions that may control virulence and transmissibility in humans
[5]. Accurate and rapid detection and tracking of H5N1 will be
critical to prevent or control a potential pandemic.
Diagnosis of influenza type A infections in clinical microbiology
laboratories has traditionally been performed using cell culture
and/or direct fluorescent antibody assays [5–7]. These methods
are time-consuming and require biosafety level 3 enhanced
biocontainment facilities and equipment to protect laboratory
personnel from exposure to H5N1 cultured in the laboratory.
Because these facilities not widely available, culture-based assays
are increasingly being replaced in clinical settings by the various
polymerase chain reaction (PCR) methods [8–11].
PCR is more sensitive than traditional tests and detection does
not require viable virus or morphologically intact infected cells in
the sample. A PCR-based molecular diagnostic test is currently the
most widely used by public health laboratories to diagnose the
presence of H5N1 in clinical specimens [12]. We hypothesized
that coupling a PCR assay to a rapid sequencing method would
further increase the value of molecular techniques for virus
identification and characterization, especially if implemented into
automated robotic platforms in the near future. Nucleic acid
sequencing is considered the most reliable and highest-resolution
method for virus identification, but is typically too slow and costly
to use as a primary assay. Samples can be prepared sequentially
for PCR diagnosis of H5N1 influenza virus, and pyrosequencing,
yielding results in approximately 90 minutes, with immediate
availability of the viral sequence data. The speed, sensitivity,
precision, low cost, and high throughput of this method give it
substantial advantages in H5N1 influenza characterization. We
have designed an assay that focuses on three biologically
significant regions of the H5N1 hemagglutinin gene (Figure 1),
including sites informative of viral ancestry.
Influenza type A viruses have an eight-segment negative-sense
RNA genome complexed with nucleoprotein and polymerase
surrounded by the matrix protein and a lipid envelope that
contains two integral membrane glycoproteins, hemagglutinin
(HA) and neuraminidase (NA), protruding from the virion surface.
The HA binds to sialic acid-terminated glycan receptors on the
host cell surface, triggering virion uptake by endocytosis. Human
respiratory tract cells have predominantly alpha 2-6 linked sialic
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3 linked sialic acid receptors. Host-adapted human and avian
influenza viruses selectively bind to homologous variant sialoside
structures [13–15]. The HA receptor binding site is located at the
convergence of one helix, two loops and three single residues near
the top of the molecule; amino acid residues in the 184-186 (188-
190 H3) helix as well as the 130–134 (134-138 H3) and 217–224
(221-228 H3) loops make up the rims, whereas residues 91 (98
H3), 149 (153 H3) and 179 (183 H3) form the floor of the cavity
(H5 numbering; references: [16,17]). In the H3 subtype of HA,
amino acids 222 and 224 (226 and 228 H3) are major
determinants of human or avian host sialic acid specificity of the
virus; alpha 2-6 linkages in human viruses and alpha 2-3 linkages
in avian viruses [18]. Similar changes have been documented for
the H1 HA that caused the 1918 so-called Spanish influenza
pandemic [19,20]. Mutation at amino acid 223 from serine-to-
asparagine (227 in H3) in a 2003 human H5N1 isolate (A/Hong
Kong/213/03) maintained avian-like binding specificity of alpha
2-3 linked sialic acids but also had increased binding to alpha 2-6
sialic acid linkages [17].
The HA is also responsible for cell entry by mediating fusion of
the endosomal and viral membranes. The HA requires proteolytic
cleavage to become functional in membrane fusion. Cleavage,
mediated by host proteases, results in two disulfide-linked subunits,
HA1 and HA2. The HA1 region of the HA gene encompasses
three sites of known biological significance:
N A glycosylation sequon at the top of the receptor binding site at
amino acids 154-156 (of mature H5 HA1) (158-160 H3) has
been linked to viral adaptation from waterfowl to domesticated
poultry. The majority of H5N1 viruses isolated from humans
since 2004 have this motif [4,21].
N The receptor binding site. Changes in the rims or floor of the
receptor-binding site thought to favor binding of human forms
of cell surface sialosides are considered critical for sustained
transmission in the human population.
N Finally, the number of basic amino acids (lysine or arginine) in
the cleavage site between HA1 and HA2 determines whether
the virus is highly pathogenic for birds [22,23]. All Eurasian
H5N1 viruses currently circulating are highly pathogenic and
contain either five or six consecutive basic amino acids at this
site [4].
Recent phylogenetic analysis of H5N1 evolution indicates that
distinct major and minor clades have emerged among HA gene
lineages; the two most important ones of these from a public health
perspective are termed clades 1 and 2. These two clades are
identifiable with two amino acids, 124 and 212 (129 and 216 in
H3) [4]. These clade distinctions may be antigenically significant;
therefore clade identification may aid selection of appropriate
vaccines. Rapid H5N1 identification will assist in pinpointing the
source of particularly virulent outbreaks, and in targeting limited
supplies of vaccines and anti-virals to key regions.
Figure 1. Primers, markers and key sites on H5N1 influenza A hemagglutinin gene. A region of 768 bases of cDNA of the hemagglutinin gene of nine
strains of H5N1 was assayed to obtain sequence information for three key biologically significant sites (glycosylation, receptor specificity, and HA1/
HA2 cleavage; (sites indicated in red)). Two markers (green) distinguish clades of H5N1. Three additional polymorphic sites (yellow) provide
unambiguous strain identification. The PCR primers used to bracket this region are indicated in purple; internal primers are blue.
doi:10.1371/journal.pone.0000095.g001
H5N1 Influenza Viruses
PLoS ONE | www.plosone.org 2 December 2006 | Issue 1 | e95Here, we report the results of a proof-of-principle experiment
based on the application of pyrosequencing technology targeting
the hemagglutinin gene of H5N1 influenza. The assay uses RT-
PCR to amplify a known H5N1-specific region of 768 nucleotides.
Subsequent pyrosequencing [24] of strains that are H5N1-positive
with ten specific sequencing primers is used to determine HA clade
and strain, receptor binding preference, low- or high-pathogenicity
cleavage site, and glycosylation status. The assay presented here is
considerably more informative than traditional techniques such as
real-time PCR, as it not only identifies the H5N1 lineage but also
predicts receptor binding properties that could herald the
development of human-human transmissibility. This assay would
be most advantageous as part of a screening method during high-
volumes of H5N1 activity. Also, pyrosequencing has some
advantages over Sanger sequencing-based methods, specifically
the availability of sequence data directly following the sequencing
primer, and the accessibility of the results in real time. Moreover,
this assay is specific, rapid and cost-effective.
RESULTS
HA Amplification by PCR
The first step in the analysis of a clinical specimen or a viral isolate
in our assay is the generation of a DNA copy of the viral RNA,
which is accomplished by reverse transcription coupled to PCR
(RT-PCR). This was performed using two different biotinylated
combinations of PCR primers specific to the H5N1 regions of
interest in order to achieve optimal sequencing flexibility of H5N1
isolates, as listed in Figure 2. As shown in Figure 3, either pair of
primers provided reliable amplification of H5N1, and neither
generated products when used in PCRs with negative controls
(total genomic DNA from unrelated human cell lines) (confirmed
by Sanger sequencing).
All of the H5N1 PCR products were sequenced at least twice
both by Sanger dideoxy sequencing and pyrosequencing; PCR-
positive amplicons generated correct sequence results independent
of sequencing method or fragment size. Furthermore, no loops or
primer-dimers were observed when primers were pyrosequenced
in the absence of template. Representative and typical pyrograms
of sample A/Vietnam/HN30408/ 2005, obtained by pyrosequen-
cing, are shown in Figure 4; pyrograms for the remaining eight
samples are available as supplementary information. The
pyrosequencing run covering the required 14 bases took
approximately 15 minutes.
HA Pyrosequencing
The results of our pyrosequencing assay clearly distinguished the
nine different strains of H5N1 avian influenza, based on eight sites,
as shown in Table 1. Furthermore, this approach provided
accurate sequencing of regions of known biological significance
(for supplementary data, see http://bioel.stanford.edu/avianflu/
index.html). The results of this assay can be seen in Table 2, which
shows the amino acid sequences characteristic of each strain
tested.
In order to characterize the strains based on the HA sequence,
pyrograms obtained via pyrosequencing were visually inspected to
verify the sequences of functionally relevant sites and the presence
of polymorphisms that could serve as lineage markers. These
sequences were then compared to known H5N1 sequences for
Figure 2. Phylogenetic relationships of H5N1 hemagglutinin (HA) genes from highly pathogenic H5N1 avian influenza viruses used in this study.
Phylogenetic trees were inferred from nucleotide sequences by the neighbor joining method in the MEGA program. Horizontal distances are
proportional to the number of nucleotide changes between the viruses. HA clade determinations are shown on the right.
doi:10.1371/journal.pone.0000095.g002
Figure 3. Amplicon DNA yield from PCR with different combinations of
biotinylated primers. All PCR products were Sanger-sequenced to
confirm the identity of the sample. A) The nine H5N1 samples amplified
with a biotinylated forward primer (B-F-H5N1-1) and nonbiotinylated
reverse primer (R-H5N1-2). From left to right, the samples are A/goose/
Guangdong/1/96 (AF144305), A/Hong Kong/156/97 (AF036356), A/
Hong Kong/483/97 (AF046097), A/Hong Kong/213/2003 (AY575869), A/
chicken/Korea/ES/03 (AY676035), A/Vietnam/1203/2004 vaccine candi-
date with deletion of polybasic cleavage site (AY651334), A/Vietnam/
JP14/2005 (ISDN117778), A/Vietnam/HN30408/2005 (ISDN119678), A/
Indonesia/5/05 (ISDN125873). B) The H5N1 PCR products amplified with
a biotinylated reverse primer (B-R-H5N1-3) and a nonbiotinylated
forward primer (F-H5N1-4). Samples are in the order stated for part (A).
doi:10.1371/journal.pone.0000095.g003
H5N1 Influenza Viruses
PLoS ONE | www.plosone.org 3 December 2006 | Issue 1 | e95Figure 4. Panels A–I: Pyrograms obtained by pyrosequencing of sample A/Vietnam/HN30408/2005 with the HS 96 system. Peaks above a given
nucleotide sample indicate nucleotide incorporation (with height proportional to number of consecutive incorporation events). Initial
pyrosequencing was performed with systematic nucleotide dispensation for de novo sequencing (pre-programmed dispensation runs can also be
performed). Panel J: Map of the HA sequence of A/Vietnam/HN30408/2005 obtained by Sanger sequencing; pyrosequencing data is overlaid and
color-coded to show correlation between the sequence data obtained by the two methods. Reverse-primed pyrosequencing results should be read
as reverse complements. For clarity, primers and biologically significant sequence segments are colored to correspond to the sequence map
presented in Figure 1.
doi:10.1371/journal.pone.0000095.g004
H5N1 Influenza Viruses
PLoS ONE | www.plosone.org 4 December 2006 | Issue 1 | e95T
a
b
l
e
1
.
S
e
q
u
e
n
c
e
s
o
f
H
5
N
1
c
l
a
d
e
m
a
r
k
e
r
s
a
n
d
a
c
t
i
v
e
s
i
t
e
s
,
a
s
d
e
t
e
r
m
i
n
e
d
b
y
p
y
r
o
s
e
q
u
e
n
c
i
n
g
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
l
a
d
e
M
a
r
k
e
r
1
S
t
r
a
i
n
M
a
r
k
e
r
1
G
l
y
c
o
s
y
l
a
t
i
o
n
S
i
t
e
S
t
r
a
i
n
M
a
r
k
e
r
2
C
l
a
d
e
M
a
r
k
e
r
2
(
F
)
C
l
a
d
e
M
a
r
k
e
r
2
(
R
)
R
e
c
e
p
t
o
r
S
p
e
c
i
f
i
c
i
t
y
S
i
t
e
S
t
r
a
i
n
M
a
r
k
e
r
3
C
l
e
a
v
a
g
e
S
i
t
e
g
o
o
s
e
/
G
u
a
n
g
d
o
n
g
/
1
/
9
6
A
A
C
C
T
G
G
T
T
C
T
T
G
A
A
A
C
C
C
A
T
C
A
A
T
G
G
G
A
G
G
T
C
C
T
C
C
T
T
T
T
T
T
C
A
G
A
A
A
G
T
G
C
A
T
A
C
C
C
A
A
C
A
A
T
A
A
A
G
A
C
A
A
A
G
C
T
C
T
A
T
A
C
C
A
G
A
A
A
T
A
G
C
T
A
C
T
A
G
A
C
C
A
A
A
G
A
C
C
T
T
G
G
T
T
G
T
A
A
G
A
A
G
G
T
G
A
A
A
C
G
G
G
C
A
A
A
T
G
A
A
A
C
C
C
A
G
A
C
T
C
T
A
G
T
A
T
G
C
C
A
A
G
A
A
G
A
A
G
A
A
A
A
A
A
G
A
G
A
G
A
G
G
A
H
o
n
g
K
o
n
g
/
1
5
6
/
9
7
A
A
C
C
T
G
G
T
T
C
T
T
G
A
A
A
C
C
C
A
T
C
A
T
T
G
G
G
A
G
G
T
C
C
T
C
C
T
T
T
T
T
C
A
G
A
G
T
A
C
A
T
A
C
C
C
A
A
C
A
A
T
A
A
A
G
A
G
A
C
A
A
A
G
C
T
C
T
A
T
C
C
A
G
A
A
A
T
A
G
A
G
A
C
C
T
T
G
G
T
T
A
G
A
G
A
G
T
A
A
G
A
A
G
G
T
G
G
A
A
A
C
G
G
G
C
A
A
A
T
G
C
T
C
T
A
G
T
A
T
G
C
C
A
A
G
A
A
G
A
A
G
A
A
A
A
A
A
G
A
G
A
H
o
n
g
K
o
n
g
/
4
8
3
/
9
7
A
A
C
C
T
G
G
T
T
C
T
T
G
A
A
A
C
C
C
A
T
C
A
T
T
G
G
G
A
A
G
T
C
C
T
C
C
T
T
T
T
T
C
A
G
A
G
T
A
C
A
T
A
C
C
C
A
A
C
A
A
T
A
A
A
G
A
G
A
C
A
A
A
G
C
T
C
T
A
T
C
C
A
G
A
A
A
T
A
G
A
G
A
C
C
T
T
T
G
G
T
T
A
T
A
A
G
A
A
G
G
T
G
A
A
A
C
G
G
G
C
C
T
C
T
A
G
T
A
T
G
C
C
A
A
G
A
A
G
A
A
G
A
A
A
A
A
A
G
A
G
A
H
o
n
g
K
o
n
g
/
2
1
3
/
0
3
G
A
C
C
T
G
G
T
T
C
T
T
A
A
A
C
C
C
A
T
C
A
A
A
G
G
A
A
A
G
T
C
C
T
C
C
T
T
T
T
T
C
A
G
A
T
G
C
A
T
A
C
C
C
A
A
C
A
A
T
A
A
G
A
C
T
A
G
G
C
T
C
T
A
A
C
C
A
A
A
A
A
A
A
A
C
C
A
T
G
G
T
T
A
G
A
G
A
C
C
A
A
A
T
C
A
C
A
G
T
A
G
G
A
A
G
G
T
A
A
A
A
C
C
T
C
T
A
G
T
A
T
G
C
C
A
G
A
A
G
A
A
G
A
A
A
A
A
A
G
A
G
A
G
G
A
c
h
i
c
k
e
n
/
K
o
r
e
a
/
E
S
/
0
3
A
G
C
C
T
G
G
T
T
C
T
T
G
A
A
A
C
C
C
A
T
C
A
A
G
G
G
A
A
G
G
T
C
C
T
C
C
T
T
C
T
T
C
A
G
A
A
A
G
T
G
C
A
C
T
A
C
C
C
A
A
C
A
A
T
A
A
A
G
A
C
A
A
G
A
C
T
C
T
A
A
C
C
A
A
A
A
A
A
A
A
C
C
A
T
G
G
T
T
A
G
A
G
A
C
A
A
G
T
A
G
G
A
A
G
G
T
G
A
A
A
C
G
G
G
C
A
C
T
C
T
A
G
T
A
A
A
A
A
G
A
A
A
A
A
A
G
A
G
A
V
i
e
t
n
a
m
/
1
2
0
3
/
0
4
G
A
C
C
T
G
G
T
T
C
T
T
G
A
A
A
C
C
C
A
T
C
A
A
G
G
G
A
A
A
A
G
T
C
C
T
C
C
T
T
T
T
T
C
A
G
A
G
T
A
C
A
T
A
C
C
C
A
A
C
A
A
T
A
A
A
G
A
G
A
C
A
A
A
G
C
T
C
T
A
A
C
C
A
A
A
G
A
A
u
n
r
e
a
d
a
b
l
e
G
T
A
G
G
A
A
G
G
T
G
A
A
A
C
G
G
G
G
C
C
T
C
T
A
G
C
A
T
G
C
C
A
u
n
r
e
l
i
a
b
l
e
V
i
e
t
n
a
m
/
J
P
1
4
/
0
5
G
A
C
C
T
C
G
G
T
C
T
T
A
G
G
G
A
A
A
G
T
C
C
T
C
C
T
T
T
T
T
C
A
G
A
A
A
G
T
A
C
A
T
A
C
C
A
A
C
A
A
T
A
A
A
G
A
A
A
G
A
C
A
A
A
G
C
T
C
T
A
A
C
C
A
A
G
A
A
G
A
A
A
C
C
C
A
T
G
G
G
T
A
G
G
A
G
G
G
T
G
A
A
A
C
G
G
G
C
C
T
C
T
A
G
T
A
T
G
C
C
A
C
A
G
A
A
G
A
A
G
A
A
A
A
A
A
G
A
G
A
V
i
e
t
n
a
m
/
H
N
3
0
4
0
8
/
0
5
C
A
G
C
C
T
G
G
T
T
C
T
T
G
A
A
A
C
C
C
A
T
C
A
A
G
G
G
A
A
A
G
T
C
C
T
C
C
T
T
T
T
T
C
A
G
A
A
A
G
T
A
C
A
T
A
C
C
C
A
A
C
A
A
T
A
A
G
A
G
A
C
A
A
A
G
C
T
C
T
A
A
C
C
G
A
A
G
A
A
G
A
A
A
C
C
C
A
T
G
G
T
T
A
G
A
G
A
C
C
A
A
A
T
G
T
A
G
G
A
A
G
G
T
G
T
T
C
T
A
G
T
A
T
G
C
C
A
A
G
A
A
G
A
A
A
A
A
A
G
A
G
A
G
G
I
n
d
o
n
e
s
i
a
/
5
/
0
5
C
A
G
C
C
T
G
G
T
T
C
T
T
G
A
A
A
G
G
G
A
T
C
A
T
G
G
G
A
A
G
T
C
C
C
T
C
C
T
T
T
T
T
T
A
G
A
G
T
A
C
A
T
A
C
C
C
A
A
C
A
A
T
A
A
A
G
A
A
G
A
C
A
A
G
G
C
T
A
T
A
A
C
C
A
A
A
G
A
A
A
A
A
C
C
G
T
A
G
G
A
A
G
G
T
G
A
A
A
C
G
G
G
C
C
T
C
T
A
G
T
A
T
G
C
C
A
A
G
C
A
G
A
A
G
A
A
A
A
A
A
G
A
G
A
S
a
m
p
l
e
s
t
r
a
i
n
s
a
r
e
l
i
s
t
e
d
i
n
t
h
e
l
e
f
t
m
o
s
t
c
o
l
u
m
n
,
s
i
t
e
o
f
s
e
q
u
e
n
c
e
i
n
f
o
r
m
a
t
i
o
n
i
n
t
h
e
t
o
p
r
o
w
.
‘
‘
F
’
’
o
r
‘
‘
R
’
’
i
n
d
i
c
a
t
e
s
w
h
e
t
h
e
r
t
h
e
p
r
i
m
e
r
i
s
f
o
r
w
a
r
d
-
o
r
r
e
v
e
r
s
e
-
d
i
r
e
c
t
e
d
.
T
h
e
5
9
-
3
9
s
e
q
u
e
n
c
e
s
p
r
e
s
e
n
t
e
d
h
e
r
e
w
e
r
e
o
b
t
a
i
n
e
d
b
y
r
e
a
d
i
n
g
p
y
r
o
g
r
a
m
s
(
a
s
r
e
v
e
r
s
e
c
o
m
p
l
e
m
e
n
t
s
w
h
e
n
u
s
i
n
g
a
r
e
v
e
r
s
e
-
d
i
r
e
c
t
e
d
s
e
q
u
e
n
c
i
n
g
p
r
i
m
e
r
)
.
d
o
i
:
1
0
.
1
3
7
1
/
j
o
u
r
n
a
l
.
p
o
n
e
.
0
0
0
0
0
9
5
.
t
0
0
1
..................................................................................
H5N1 Influenza Viruses
PLoS ONE | www.plosone.org 5 December 2006 | Issue 1 | e95clade and strain identification. Certain positions provided essential
information for the identification of signatures important for
public health, such as changes in the receptor binding site which
could signal an increase in the ability of the virus to transmit from
human- to-human. The prototype receptor binding site for avian
isolates in amino acids 221-224 of the HA1 is GQSG. One human
isolate, Hong Kong/213/03, has a mutation at amino acid 223,
S-.N, which switches the affinity of the hemagglutinin from alpha
2-3 linked sialic acid to the alpha 2-6 linked sialic acid preferred by
human influenza viruses. This mutation was detected by a single
nucleotide change, G-.A, in the sequence of the receptor binding
active site. Rapid characterization of the receptor binding active
site and other active sites of the hemagglutinin is critical in
identifying viruses with increased pandemic potential.
DISCUSSION
Our initial results indicate that targeted pyrosequencing approach
can clearly distinguish among different strains of H5N1, and can
accurately sequence regions of known biological significance such
as receptor binding (supplementary data: http://bioel.stanford.
edu/avianflu/index.html). The HA sequence results obtained by
pyrosequencing were 100% identical to those obtained by the
Sanger method (two replicates were performed to cross-verify
results). Three pyrosequencing replicates, with nine samples at ten
sites, were performed: two with a de novo dispensation and one with
a pre-programmed dispensation order. Of the three pyrosequen-
cing replicates performed, all successful runs verified one another.
Because Sanger sequencing relies on molecular separation of the
polymerase-mediated extension of the primer, the first ,20–50
bases 39 of the primer are not discernible. In contrast,
pyrosequencing provides unambiguous sequence from the first
nucleotide 39 to the primer, increasing the sequence information
yield per assay. This feature of pyrosequencing was exploited by
designing H5N1-specific primers adjacent to critical polymorphic
sites such that the initial base-callings are usually sufficient to
determine the lineage of a given HA gene.
A simpler detection assay giving a positive or negative
identification of H5N1 will be helpful, but a more information-
rich method is necessary to provide additional information to
guide patient care or public health measures, especially as new
strains emerge. Indeed, some laboratories are already using
pyrosequencing to identify drug-resistant viruses [25]. As H5N1
influenza becomes more prevalent, it will be impractical to
perform full sequencing of all isolates in time for analysis of rapidly
changing epidemiological trends. Our assay could be a valuable
complement to full sequencing at public health laboratories. We
have developed a rapid and inexpensive assay based on DNA
sequencing for early detection of virus present in host cells. This
assay permits rapid, simplified and accurate identification of avian
H5N1 influenza A, and consists of simple procedures maintaining
high sensitivity and specificity. As new sites of functional relevance
are identified, new site-specific primers can be added to broaden
the utility of the assay. Expanded knowledge of H5N1 sequence
and evolution is likely to contribute to more effective diagnostic
methods and treatments that require less investment of time and
money.
An additional advantage of pyrosequencing over the Sanger
method is its application in genotyping single and multiple HPV
infections [26]. This technology is based on the use of multiple
sequencing primers in the same pyrosequencing reaction. Pools of
primers are chosen based on their position on the target, the
sequence information they yield, and their cross-reactivity with
other primers in the multiplex assay. Clinically relevant samples
containing multiple infections can then be identified and
characterized.
These early robust results have validated our approach and
selection of specific primers. We have moved toward a further
refinement of the assay based on these results. After an initial de
novo pyrosequencing run was performed on the H5N1 samples,
sequence data for each strain were compiled for each nucleotide
site. This information was integrated to produce consensus pre-
programmed dispensation orders of nucleotides. This type of
pyrosequencing would allow us to obtain sequence results of
similarly high quality in 10 to 15 minutes (Figure 5). With this
approach, all of the H5N1 subtypes included in this study could be
positively identified. New variants would not be fully character-
ized, but would be heralded by truncated sequences.
In summary, we have developed a reliable, rapid, cost-effective,
and information-rich diagnostic assay for H5N1 influenza. This
sequence-based method could be extended to include amplicons
from other genes of interest; for example, drug targets such as NA
and the M2 ion channel [27,28], or the postulated virulence motifs
on NS1 or PB2 [29,30]. Pyrosequencing is user-friendly, and
permits significantly more efficient and rapid genotyping than
traditional techniques. This method detects a wide range of
influenza A H5N1 subtypes based on sequence information. The
assay will allow further development of technology to directly
detect H5N1 or specific strains of influenza A in clinical specimens
without extensive sample preparation.
Table 2. Characterization of the hemagglutinin from the H5N1 influenza viruses used in this study.
..................................................................................................................................................
Virus Name HA clade
Glycosylation Motif
(NXT/S, X?P) at aa 154
Receptor Binding
Site (221-224) Cleavage Motif Host/Outcome
goose/Guangdong/1/96 ancestor Present GQSG RRRKKR Goose
Hong Kong/156/97 3 Absent GQSG RRRKKR Human/Died
Hong Kong/483/97 3 Present GQSG RRRKKR Human/Died
Hong Kong/213/03 19 Present GQNG RRRKKR Human/Died
Vietnam/1203/04 1 Present GQSG RRRKKR Human/Died
Vietnam/JP14/05 1 Present GQSG RRRKKR Human/Died
Vietnam/HN30408/05 1 Present GQSG RRKKR Human/Survived
chicken/Korea/ES/03 2 Absent GQSG KRKKR Chicken
Indonesia/5/05 2 Present GQSG SRRKKR Human/Died
doi:10.1371/journal.pone.0000095.t002
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Avian Influenza A Subtypes and H5N1-Specific
Primer Design
Sequences of 362 avian influenza A virus species were acquired
from GenBank at the National Center for Biotechnology In-
formation and Influenza Sequence Database at Los Alamos
National Laboratory and aligned using Clustal X version 1.83
[31]. A specific sequencing primer was designed for H5N1, with
no sequence similarity to the other influenza virus HA subtypes
based on the database searches and alignments (Figure 1).
H5N1 Avian Influenza Virus Isolates
The viruses that formed the test set for this study were chosen on
the basis of their diversity in biologically significant regions of
hemagglutinin and/or their ability to cause infection in humans.
Virus strain names are shown in Figure 2 and accession numbers
are as follows: A/goose/Guangdong/1/96 (AF144305), A/Hong
Kong/156/97 (AF036356), A/Hong Kong/483/97 (AF046097),
A/Hong Kong/213/2003 (AY575869), A/chicken/Korea/ES/03
(AY676035), A/Vietnam/1203/2004 vaccine candidate with
deletion of polybasic cleavage site (AY651334), A/Vietnam/
JP14/2005 (ISDN117778), A/Vietnam/HN30408/2005
(ISDN119678), A/Indonesia/5/05 (ISDN125873).
RNA Extraction, RT-PCR and PCR Amplification
Viruses were isolated and propagated by inoculation into the
allantoic sac of 10-day old chicken embryos, as described
previously [32]. Viral infectivity was determined by endpoint
dilution, injection into chicken embryos and hemagglutination
assay. All work involving infectious H5N1 influenza was
performed in government-approved biosafety level 3-enhanced
containment facilities as required by the U.S. Department of
Agriculture and the Select Agent Program (see guidance at www.
cdc.gov/flu/h2n2bsl3.htm).Viral RNA was extracted using the
QIAmp vRNA Kit (Qiagen, Valencia CA). Extractions were
performed according to manufacturer’s instructions. QIAGEN
Onestep RT-PCR kit (Qiagen, Valencia CA) was used to perform
RT-PCR from 30 ng of RNA (approximate concentration of
10 ng/ml by spectrophotometer) in a 50 ml reaction volume. The
RT-PCR amplification primers, which are biotinylated F-H5N1-
1/3 (59-TCAAYGACTATGAAGAAYTGAAACA-39), and R-
H5N1-2/4 (59- AACCATCTACCATTCCCTGCCATCC-3)
were synthesized by IDT (Coralville, IA, USA). RT-PCR was
performed with a DNA Engine (PTC-200) Peltier Thermal Cycler
(BIO-RAD, Hercules, Calif.) as follows: 50uC for 10 minutes,
95uC for 15 minutes, 35 cycles of 95uC, 55uC, and 72uC for
1 minute each, and finally a 10 minute final extension at 72uC. To
confirm proper amplification, PCR products were electrophoresed
in a 1% agarose gel and visualized by ethidium bromide staining
under UV illumination.
Sanger dideoxy DNA Sequencing of PCR Products
The amplified DNA from all isolates was cycle sequenced in both
directions using the BigDye Terminators Reaction Kit v. 3.1
(Applied Biosystems, Foster City, CA) on an ABI automated DNA
sequencer (3730 XL DNA Analyzer).
Hemagglutinin Sequencing Primers
An entropy-based analysis of genetic variation among H5N1
strains (Figure 1) was used to design PCR primers [33]. The
approach focused on amplicons comprising regions for receptor
binding sites, cleavage site and glycosylation sites, along with
markers to identify clade and individual strain (Figure 1). Highly
Figure 5. A representative pyrogram illustration. Comparison of pyrosequencing results obtained using the de novo (top) and consensus pre-
programmed (bottom) sequencing methods for site 3 (a clade marker) in sample A1 (goose/Guangdong/1/96). Both methods give the sequence
GACAAAGCTCTATCAAAAC for our laboratory stock. In contrast the GenBank sequence (accession # AF144305) reads GACAAAGCTATATCAAAAC.
Database information was found to be based off wild-type sequence information, while the sample we analyzed was obtained via reverse
genetics. A longer read length is obtained via the consensus pre-programmed dispensation method (22 versus 12 nucleotides).
doi:10.1371/journal.pone.0000095.g005
H5N1 Influenza Viruses
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sequence each region of interest. The selected region is bracketed
by sequences unique to and highly conserved in the H5N1
subtype. Based on sequence alignments of H5N1 and sequencing
results (data not shown) from all the isolates, a set of sequencing
primers were designed spanning a region of the HA informative
with regards to clade, strain, receptor binding motif, cleavability
and glycosylation (Figure 1) and which specifically hybridize to
H5N1. Sequences for relevant influenza viruses with known
properties and virulence status were compiled for each sample
from pyrograms. These sequences were then compared to known
H5N1 sequences by alignment and visual inspection.
Pyroseqencing
Biotinylated PCR product (5 ng/ml) from RT step from viral RNA
(Figure 1) was immobilized onto 2.5 ml streptavidin-coated High
Performance Sepharose beads (Amersham Biosciences, Piscat-
away, NJ) by incubation at room temperature for at least
10 minutes with agitation at 1400 rpm. Single-stranded DNA
was obtained by washing the immobilized PCR product with 70%
EtOH, denatured with 0.2 M NaOH, and washed with TA-Buffer
(0.1 M Tris-Acetate, pH 7.6) using a Vacuum Prep Tool and
Vacuum Prep Worktable (Biotage, Uppsala, Sweden). The beads
were then suspended in 12 ml annealing buffer (10 mM Tris-
acetate pH 7.75, 5 mM Mg-acetate) containing 0.3 pmol se-
quencing primer. Single-stranded DNA was hybridized to the
sequencing primer by incubation at 90uC for 2 minutes, at 60uC
for 5 minutes and at room temperature for 5 minutes.
Primed single-stranded PCR products were sequenced using
PSQ
TM HS96A System (Biotage). Sequencing was performed in
a total volume of 12 ml using the PSQ 96 Gold kit (Biotage).
Consensus pre-programmed dispensation orders were determined
by integrating sequence information for each strain at a given
sequencing site [34]. See figure 5 for a comparison of de novo and
pre-programmed sequencing strategies. As shown, approximately
10 more nucleotides of sequence information are obtained with
the pre-programmed method, because nucleotide incorporations
are anticipated. This reduces the amount of time required as well
as the accumulation of sequencing byproducts. Negative-control
nucleotide dispensations were also included in the program to
check for insertions and to measure background signals. The
identity and number of nucleotide extension events were de-
termined by automated measurement of the amount of light
generated after incorporation of each dNTP.
Raw data were interpreted using software developed specifically
for this purpose,‘‘Classifier.’’ Classification of samples by strain is
straightforward using the short sequence segments obtained. We
use a Support Vector Machine [35] approach implemented in the
statistical programming language R [36] to classify a given sample
with statistical accuracy. This provides an automated sample
identification tool, designed for eventual use with large numbers of
source sequences [37,38].
Supplementary information
See http://bioel.stanford.edu/avianflu/index.html for detailed
pyrosequencing results for all nine strains.
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